B2V351 AF NFT

Aspartate--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidl7spsny5crs44gpzk35pi7qkufl6bbbl3kms5lfowleb7t7hgzu/metadata.json
IPFS of structure file: 
bafybeicrglfpr2465h5njei72uyggol2yqq6qgdr6fnwqttom72ljuh26a/AF-B2V351-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7025bA95cbd795796733105284DD3E7B741Ab901
First NFT owner address (bech32): 
genesis1wqjm49wt672hjeenzpfgfhf70d6p4wgp99rgvp
Current NFT ID #444940 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
444940
Accession (UniProt):
B2V351
Name::
Aspartate--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V351 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V351|SYD_CLOBA Aspartate--tRNA ligase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=aspS PE=3 SV=1 MGEALNGLKRTMMCGEPREEHVGQKITLMGWVQRNRKLGGLDFIDLRDKTGIMQVVFGEEINAEAFEKAKGVRPEYCIAVTGEVVKRESVNENMPTGFVELKCQSLKILSESETPPIYIKENLDAAENIRLKYRYLDLRRPDMHRIFEIRSKTTKSIRDYLEKNDFLDVETPMLTKSTPEGARDYLVPSRNYPGMFYALPQSPQIFKQLLMVSGFDKYYQIVKCFRDEDLRANRQPEFTQVDMELSFVEQDDIMALNEGLIAHVFKEVAGVDVKLPIKRMTFKDAMEKYGSDKPDLRFGMEITNITEDVKDMDFVVFKSAIEAGGSVRALCLKGGAALGRKPLDKLGEFVKTYKAKGLAWIQLKEDGVKSSIAKFLTDDVTNSIIETMGAETGDAILIVADKESVVFQSLGALRLELAKQFELIKDKNEFNFTWITEFPLFEYSEEEERYTACHHPFTAPMEEDLDFLESAPGKVRSKAYDLVLNGEELGGGSIRIHDMELQQRMFKALGFTEEQAWERFGFLLQAFKFGPPPHGGLAFGLDRMIMFLAGTENIKDVIAFPKNQNAYCYLSEAPNIADEKQLTELGIGILPKQEKQEQE